ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1107

Are Rheumatologists Correctly Identifying and Controlling Traditional Cardiovascular Risk Factors?

Dionicio Galarza-Delgado 1, Jose Azpiri-Lopez 1, Iris Colunga-Pedraza 1, Iván de Jesús Hernández-Galarza 1, Ileana Cecilia Reynosa-Silva1, Karla Paola Cuellar-Calderon 1, Marielva Castro-Gonzalez 1 and Carolina Marlene Martinez-Flores 1, 1Universidad Autonoma de Nuevo Leon, Hospital Universitario "Dr Jose Eleuterio Gonzalez", Monterrey, Nuevo Leon, Mexico

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Cardiovascular disease, hypertension, Rheumatic disease, rheumatic education and prevention

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 11, 2019

Title: Epidemiology & Public Health Poster II: Spondyloarthritis & Connective Tissue Disease

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Chronic systemic inflammation generated by rheumatic diseases (RD) is related to the increased cardiovascular risk (CVR) in this population. However, the coexistence of traditional CVR factors such as diabetes, hypertension, obesity, smoking, and dyslipidemia, further increases CVR burden. Through an adequate control of this factors, CVR can be decreased. But to achieve this, primary care physicians and rheumatologists should be aware of how relevant it is to make frequent cardiovascular assessment to RD patients. Therefore, the aim of this study is to determine the prevalence of underdiagnosis and inefficient treatment of traditional cardiovascular risk factors in RD patients.

Methods: An observational, retrospective study of patients between 30 and 75 years with rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus and ankylosing spondylitis. Patient information was obtained from March 2018 to April 2019 through the REPAIR® software, an electronic records database used at the rheumatology clinic at a University Hospital in northeastern Mexico. Exclusion criteria: previous atherosclerotic cardiovascular disease, overlap syndromes, diabetes, or pregnancy. Evaluation included history of lifestyle, comorbidities, use of corticoids, blood pressure, anthropometry and fasting glucose measures. Framingham-Body Mass Index (FRS-BMI) was used to calculate their predicted CVR to 10 years.

Results: A total of 451 patients were recruited, 90.2% were women, with a median age of 52 years (43-59). In this population, 80.2% of the patients had at least one CVR factor; the presence of traditional CVR factors according to RD is shown in Figure 1. Other population characteristics are in Table 1.  More than half of the patients were not in their ideal weight, 37.2% being diagnosed as overweight and 32.8% with obesity. Out of the patients with no previous diagnosis of hypertension (n=416, 92.2%), 25.96% had elevated or high blood pressure levels. From the patients that previously had hypertension, 65.7% did not have an adequate control of their blood pressure, even though they were on pharmacological treatment. History of dyslipidemia was found in 4.9% of patients. Half of them arrived at consultation with a recent lipid profile, having a median LDL of 133.5 (109-158) mg/dL, not meeting target levels.  Even though no diabetic patients were included, 22.8% of the patients had hyperglycemia. According to FRS-BMI, 82% of the patients had a low CVR, 13.7% moderate risk, and 4.2% had a high CVR.

Conclusion: This study suggests that traditional CVR factors are underdiagnosed and insufficiently treated in RD patients. The previous is alarming, because 80.2% of the patients have at least one CVR factor, and they could highly benefit from its adequate control. Besides having a RD and at least one traditional CVR factor, 17.9% of the patients had a moderate or high CVR according to FRS-BMI. Rheumatologists should become more aware of the increased CVR in RD patients, and make CV assessment a part of their routine.


Figure 1 CVR factors

Figure 1. Traditional CV risk factors by RD.


Table 1 CVR factors

Table 1. Demographic characteristics.


Disclosure: D. Galarza-Delgado, None; J. Azpiri-Lopez, None; I. Colunga-Pedraza, None; I. Hernández-Galarza, None; I. Reynosa-Silva, None; K. Cuellar-Calderon, None; M. Castro-Gonzalez, None; C. Martinez-Flores, None.

To cite this abstract in AMA style:

Galarza-Delgado D, Azpiri-Lopez J, Colunga-Pedraza I, Hernández-Galarza I, Reynosa-Silva I, Cuellar-Calderon K, Castro-Gonzalez M, Martinez-Flores C. Are Rheumatologists Correctly Identifying and Controlling Traditional Cardiovascular Risk Factors? [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/are-rheumatologists-correctly-identifying-and-controlling-traditional-cardiovascular-risk-factors/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/are-rheumatologists-correctly-identifying-and-controlling-traditional-cardiovascular-risk-factors/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology